4.7 Article

Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway

Journal

NUTRIENTS
Volume 14, Issue 14, Pages -

Publisher

MDPI
DOI: 10.3390/nu14142809

Keywords

thymol; liver injury; inflammation; NLRP3 inflammasome; mTOR; autophagy

Funding

  1. National Natural Science Foundation of China [32172751]
  2. China Postdoctoral Science Foundation [2021T140103]
  3. Heilongjiang Provincial Postdoctoral Science Foundation [LBH-TZ2005]
  4. Department of Education, Heilongjiang Province [UNPYSCT-2020094]

Ask authors/readers for more resources

Thymol has been shown to protect the liver from LPS-induced injury by inhibiting the activation of NLRP3 inflammasome. It alleviates inflammatory cell infiltration and structural damage in the liver, and reduces the levels of liver damage indicators. Additionally, thymol regulates the activity of lactate dehydrogenase and the expression of inflammatory cytokines and apoptosis-related genes, thereby exerting a protective effect on the liver.
Thymol is a natural antibacterial agent found in the essential oil extracted from thyme, which has been proven to be beneficial in food and medicine. Meanwhile, the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and autophagy have been reported to play key roles in the progression of liver injury. However, the effects of thymol on the NLRP3 inflammasome and autophagy in protecting the liver remain unclear. The present study used a mouse model with liver injury induced by lipopolysaccharides (LPS) to investigate the regulatory mechanisms of thymol. We found that thymol alleviated LPS-induced liver structural damage, as judged by reduced inflammatory cell infiltration and improved structure. In addition, elevated levels of the liver damage indicators (alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (TBIL)) dropped after thymol administration. The mRNA and protein expression of inflammatory cytokines (tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-22), apoptosis-related genes (caspase3 and caspase9), and the activity of apoptosis-related genes (caspase3 and caspase9) were increased in LPS-treated livers, whereas the changes were alleviated after thymol administration. Thymol inhibited LPS-induced increment in lactate dehydrogenase (LDH) activity in primary hepatocytes of the mouse. In addition, thymol protected mice from liver injury by inhibiting NLRP3 inflammasome activation induced by LPS. Mechanistically, the present study indicates that thymol has liver protective activity resulting from the modulation of the AMP-activated protein kinase-mammalian target of rapamycin (AMPK-mTOR) to regulate the autophagy pathway, hence curbing inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available